Unknown

Dataset Information

Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration.


ABSTRACT: Several studies showed a potential anti-tumor role for cannabinoids, by modulating cell signaling pathways involved in cancer cell proliferation, chemo-resistance and migration. Cannabidiol (CBD) was previously noted in multiple myeloma (MM), both alone and in synergy with the proteasome inhibitor bortezomib, to induce cell death. In other type of human cancers, the combination of CBD with Δ9-tetrahydrocannabinol (THC) was found to act synergistically with other chemotherapeutic drugs suggesting their use in combination therapy. In the current study, we evaluated the effects of THC alone and in combination with CBD in MM cell lines. We found that CBD and THC, mainly in combination, were able to reduce cell viability by inducing autophagic-dependent necrosis. Moreover, we showed that the CB

SUBMITTER: Nabissi M 

PROVIDER: S-EPMC5363603 | biostudies-literature | 2016 Nov

REPOSITORIES: biostudies-literature